Aravive, Inc. (ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis, today announced that Jay Shepard intends to step down as President, Chief Executive Officer (CEO) and member of the Board
Name: Jay Shepard
Company: Aravive, Inc.
Position: CEO & President
Announcement Date: August 07, 2019, 10:00pm
This post was created with our easy submission form. Create your post!